[Skip to Content]
[Skip to Content Landing]
Citations 0
Correction
October 2005

Error in Figure in: A Replication-Selective Adenoviral Vector for Head and Neck Cancers

Arch Otolaryngol Head Neck Surg. 2005;131(10):920. doi:10.1001/archotol.131.10.920

In the Original Article by Tanaka et al titled “A Replication-Selective Adenoviral Vector for Head and Neck Cancers,” published in the July issue of the Archives (2005;131:630-634), an error occurred on page 633 in Figure 3B. In that figure, the lines connecting the data points were inadvertently omitted. The entire correct Figure 3 is reprinted here with its legend. The journal regrets the error.

Figure 3.
Inhibition of human head and neck squamous cell carcinoma and 293 cell lines in vitro. Ad-COX2-E1a significantly inhibited cancer cell growth (A), whereas Ad-CMV-βgal did not affect the cell growth of head and neck squamous cell carcinoma cell lines (B). The survival rates were calculated on the assumption that the rate of noninfected cells was 100%. Each point represents triplicate averages with standard deviation bars. MOI indicates multiplicities of infection.

Inhibition of human head and neck squamous cell carcinoma and 293 cell lines in vitro. Ad-COX2-E1a significantly inhibited cancer cell growth (A), whereas Ad-CMV-βgal did not affect the cell growth of head and neck squamous cell carcinoma cell lines (B). The survival rates were calculated on the assumption that the rate of noninfected cells was 100%. Each point represents triplicate averages with standard deviation bars. MOI indicates multiplicities of infection.

×